Anti-diabetes drugs are a kind of drugs that lower abnormally high levels of glucose in the blood, a characteristic of endocrine disorders known as diabetes mellitus. Anti-diabetes drugs are medicines designed to stabilize and control blood sugar levels in diabetics. Anti-diabetes drugs are often used to treat diabetes. There are various types of anti-diabetes drugs such as insulin, pramlintide (amylin), GLP1 receptor agonists (such as Vietta and Victorosa), and oral hypoglycemic agents (tablets). Type I diabetes is a condition in which the body does not produce insulin. Therefore, insulin is the only treatment effective for type 1 diabetes. Injected insulin acts just like naturally occurring insulin to lower blood glucose levels. Type 2 diabetes initially has insulin resistance, this happens when the cells of the body do not respond to insulin in the same way as people without diabetes. Oral antidiabetic agents work in various ways to reduce blood sugar levels in people with type 2 diabetes, some stimulate insulin secretion by the pancreas, and others improve the responsiveness of cells to insulin or prevent glucose production by the liver. Others slow the absorption of glucose after meals. Many people with type 2 diabetes ultimately need insulin to control their high blood sugar levels. Each class of medicine has one or more medicines. Some of these drugs are taken orally, while others require injections. Drugs included older standbys such as metformin and insulin, and sulfonylurea drugs such as glipizide (glucotrol) and glimepiride (amalyl). Other studies have considered newer and more expensive classes, including thiazolidinediones such as pioglitazone (Actos) and rosiglitazone (Avandia). DPP inhibitors such as sitagliptin (Januvia) and saxagliptin (Onglyza). Many studies tested only a single drug, but more than 100 studies used the drug in combination with metformin. Overall, it is found that metformin worked as well as or better than other drugs in lowering blood sugar levels. When it comes to preventing complications and prolonging people's lifespan, a single drug or drugs combination was unnoticeable. Diabetes is a complex chronic disease associated with hyperglycemia or a hyperglycemic condition caused by a deficiency of insulin secretion, action, or both. Chronic metabolic imbalances associated with this disease increase the risk of long-term macro vascular and micro vascular complications in patients and, if not managed with quality care, the risk of Cardiovascular Disease (CVD). The types of medication you are offered could depend on a variety of factors as different medication have different advantages and disadvantages. Anti-diabetics are not intended to treat diabetes, but they can help diabetics manage their condition and reduce the risk of diabetic complications. People with diabetes may need to take anti-diabetic drugs for life to control their blood sugar levels and avoid hypoglycemia and hyperglycemia. The Journal of Bioequivalence & Bioavailability (JBB) is an academic journal that encompasses a wide range of current research on FDA Bioequivalence, Bioequivalence antipsychotics, Bioequivalence anticancers, Bioequivalence antidiuretics, Bioequivalence antipsychotics, BA/BE Studies, Biosimilars, Advances in Bioavailability and offers a promising platform for the authors to make their valuable contributions towards the journal. Visit: https://www.walshmedicalmedia.com/bioequivalence-bioavailability.html Submit Manuscript at: https://www.walshmedicalmedia.com/submissions/bioequivalence-bioavailability.html Instructions for Authors: https://www.walshmedicalmedia.com/bioequivalence-bioavailability/instructionsforauthors.html Journal Archive: https://www.walshmedicalmedia.com/bioequivalence-bioavailability/archive.html